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ABSTRACT 
Skin blood microcirculation and the metabolism activity of tissue were examined on the patients with type 2 diabetes. 
Laser Doppler flowmetry (LDF) with 1064 nm laser light source and fluorescence spectroscopy (FS) with excitation light 
of 365 nm and 450 nm have been used to monitor the blood perfusion and the content of coenzymes NADH and FAD. 
Concluding, the proposed combined LDF and tissue FS approach allows to identify the significant violations in the blood 
microcirculation and metabolic activity for type 2 diabetes patients. 
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1. INTRODUCTION 
According to the International Diabetes Federation (IDF) report for 2015, there are 415 million diabetic patients with this 
figure projected to grow to 642 million worldwide by 20401. The diagnosis of vascular complications and monitoring of 
treatment effectiveness of diabetes is one of the most acute in modern healthcare. 
Novel compact lasers and laser systems can significantly increase reliability of the diagnostic devices for general 
practitioners and hospital clinicians and consequently improve people’s health and life expectancy. This promising 
direction in optical diagnostics development is to provide scientific and instrumental ideas and solutions for in situ 
analysis of body physiological parameters in normality/pathology. 
Beside wide applications of these methods in modern medicine, it can also be used for early foot vascular disorder 
diagnostics in patients with type 2 diabetes. 
Currently, the gold standards of diabetic foot disorder detection in surgery or hospitals are predominantly visual 
inspection and ultrasound Doppler or duplex scanning of arteries. These methods are capable of determining the level of 
trophic disorders, specificity of the haemodynamics and blood flows. However, at the distal side of feet with 
microcirculatory disorders, ultrasound Doppler is not efficient enough2. Other method like radio-contrast angiography 
have significant limitation during regular patient control: invasiveness, contrast agent toxicity and prolong exposure of 
the patient to radiation3, 4. Comparably, the new approach of transcutaneous oximetry allows one to assess the saturated 
tissue oxygen. Beside non-invasiveness, this method is time-consuming and demonstrates low accuracy due to different 
clinical factors5, 6. Another widely used approach  is thermal imaging which reveals thermoasymmetry zones on the foot 
surface, however, it demonstrates low accuracy in defining the boundaries of the trophic lesions7, 8. 
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In recent years, optical methods of microvasculature diagnosis have been actively developed, in particular laser Doppler 
flowmetry (LDF)9, 10, as well as methods based on the analysis of skin temperature fluctuations11. LDF is the most widely 
used method for monitoring the microcirculation, and assessing its level in tissue. However, the technique of laser 
Doppler flowmetry has some limitations related to an inadequately developed methodological base. 
This study aims to improve the diagnosis of diabetic foot by combining the most commonly used method to date with 
LDF and fluorescence spectroscopy (FS)12-14. This integration will provide a comprehensive analysis of the changes in 
the tissues of patients with diabetes, potentially increase the informative value and reliability of the diagnostic results. 
Metabolic activity is an important parameter of tissue viability. One estimate of metabolic activity is the ratio of 
coenzymes NADH and FAD, determined by the intensity of their endogenous fluorescence. Changes in the 
mitochondrial respiratory chain activity is a known consequence of disturbances in the functioning of the cells during 
different pathologies, especially at diabetes. It should assumed that the changes in the accumulation of both coenzymes 
NADH (the reduced form) and FAD (oxidized form) can most likely be acquired. Detection of such changes by 
fluorescence spectroscopy is one of the most promising directions of in vivo diagnosis15-21. 
The aim of this study was an attempt to experimentally examine the relationship between blood flow and oxidative 
metabolism and to analyse the potential parameter co-registration of blood flow and skin coenzyme fluorescence to 
diagnose disorders of the lower extremities in patients with type 2 diabetes. 
 
2. MATERIAL AND METHODS 
In complex experimental studies the tissue blood perfusion and the content of coenzyme NADH and FAD were assessed 
by LDF and FS respectively. Registered perfusion parameters and the amplitude of the coenzymes’ fluorescence were 
simultaneously evaluated using a “LAZMA MC” system (SPE “LAZMA” Ltd, Russia) in in the same tissue volume. The 
Doppler channel built on the basis of the laser module used a wavelength of 1064 nm. For fluorescence excitation of 
NADH and FAD, 365 nm and 450 nm sources of radiation were used respectively. Delivery of probing radiation and 
receiving back reflected secondary radiation from the tissue were realised by a multiple optical fibre probe (Fig. 1). 
 
 
 
Figure 1. The general scheme of “LAZMA MC” system. 
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A specialised software was developed to work with the system. This allowed for real-time control of the course of the 
experiment and analysis of recorded parameters, control unit and realising functional tests – thermal- and 
electrostimulation. Fig.2 shows an example of the working window of the software: top panel – the registered 
fluorescence spectrum at UV radiation; bottom panel – registered LDF-grams during the heating of samples with 
different modes. 
 
 
Figure 2. An example of the working window of the software for “LAZMA MC” with an actual records of the foot skin 
fluorescence and blood perfusion (lower section). 
 
The experimental study included two stages. The first stage was conducted in 15 patients with type 2 diabetes aged 63±7 
years (at the Endocrinology Department “Oryol Regional Hospital”). The control group consisted of 15 apparently 
healthy volunteers (mean age 53±5 years). Before investigations participants signed informed consent indicating their 
willingness to participate in the study. 
Background records (5 min) with 2 points of the top side of the foot (1st top point on the medial line of the foot, 2nd 
lowest point on the line between the 1st and 2nd metatarsal bones) on both legs (arrangement of the fibres and the foot of 
patients are presented in Fig. 3a) were obtained. The “LAZMA MC” system simultaneously recorded a pair of spectra 
during the perfusion recording, with an interval of 30 seconds. Thus, a total of 10 spectra pairs were recorded during the 
diagnostic procedure. A total of 75 patients aged 53±13 years were involved at the second stage of the experimental 
study. Local cold (25 °C) and the thermal probe (35 °C and 42 °C) was applied at this stage using the “LAZMA-TEST” 
system (SPE “LAZMA” Ltd, Russia) (Fig. 3b). The “LAZMA-TEST” system is intended for performing a selective 
functional loan on the blood microcirculatory system during investigations. The system implements a: temperature test 
(from 5 to 50 °C), skin temperature measurement and electrostimulation test. 
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                           а)                                                                                            b) 
Figure 3. The localisation of the fibre optic probe on the diabetic foot (a) and the same with Peltier thermal-pad (b) during 
the measurements. 
 
A typical example of registered fluorescence spectra and perfusion pairs using “LAZMA MC” system is presented in Fig. 4. 
Multiple parameters were analysed. The amplitude of the fluorescence INADH и IFAD, normalized to the intensity of the 
excitation radiation I365 and I450 reflected back respectively, redox ratio [Redox], the average blood tissue perfusion Im, as 
well as the proposed complex parameter, characterising the intensity of metabolic processes – metabolic rate (MR): 
     ,
I
I
I
I
[Redox]
365
450
FAD
NADH ⋅=                                                                     (1) 
     .
I
[Redox]MR
m
=                                                                    (2) 
For each 5 minute study, all indicators were averaged over 10 measurements. 
  
а) b) 
Figure 4. A typical example of fluorescence spectra (а) and blood perfusion record (b) by the “LAZMA MC” system from 
foot skin of the patients with type 2 diabetes. 
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parameter allows researchers to correlate the fundamental principle of the tissue metabolism in “oxygen delivery-
consumption” terms as an estimated balance of oxygen and nutrient delivery by blood (perfusion) and its consumption in 
the cells (NADH and FAD). Thus, the average level of MR for a group of patients in the first stage of the study was 
0.4±0.1 AU compared to the controls – 0.6±0.3 AU. 
The local thermal runaway increase in perfusion was mainly due to two mechanisms. By heating the skin to 34-35 °C 
peptidergic sensory nerves are activated. This is due to the activation of thermosensitive vanilloid receptor type 1 sensor 
(VR-1) fibre25. When skin was heated to 42 °C, vasodilation associated with the release of NO from the vascular 
endothelium is observed26, 27. During the local heating, these regulatory processes involve both arterioles and capillaries. 
Patients with type 2 diabetes exhibit dysfunction of all parts of the microvasculature in the tissue system, including the 
vascular endothelial and perivascular nerves.  Therefore, the thermal test probe can be adopted for the diagnosis of these 
disorders in diabetes foot. Insufficient increase of skin blood perfusion during the heating to 35 °C can be implemented 
as an objective criterion of sensory nerve dysfunction and a component of diabetic neuropathy. The absence of the 
proper skin blood perfusion response on the heating to 42 °C demonstrates the deficiency of the endothelium-dependent 
vasodilation mechanisms9 in diabetes. The heating test can be used as an assessment of the adaptive reserves of the 
“oxygen delivery-consumption” processes in the tissues. At high vasodilation during heating to 42 °C, with 
correspondent increase in  tissue oxygen content, the NADH is intensively oxidised in mitochondria both in healthy and 
in diabetic patients. Wherein, the dynamics of changes in NADH and FAD is more pronounced for a group of diabetic 
patients compared to the healthy ones. 
 
4. CONCLUSION 
These comprehensive experimental investigations reveal the functional state violation of lower extremities in patients 
with type 2 diabetes. They show the high sensitivity of optical non-invasive methods (laser Doppler flowmetry and 
fluorescence spectroscopy during their joint application) to detect irregularities in the haemodynamic and metabolic 
processes of the biological tissue in type 2 diabetes. 
Studies of the patients’ endocrinological profile show that the proposed original method can be used to diagnose 
disorders of the microvasculature and metabolism in the lower limbs of patients at the early stages of the disease and 
clarify the pathogenesis of “diabetic foot”. 
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